The outlook of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key territories has introduced substantial risk . Investors are now facing the effect of lower-cost alternatives, diminish